Abstract Submission

Please keep in mind that all abstracts accepted for presentation at AEPC 2026 will be eligible for fast-track peer-review consideration for publication as a full paper in European Heart Journal Open, provided the cover letter states that the work was presented at AEPC 2026. In addition, the best abstracts selected by the AEPC Congress Committee will receive full coverage of publication and Open Access fees.

 

Please take a moment to read the guidelines below before submitting your abstract.

ABSTRACT RULES

• The maximum number of authors per abstract is 15.
• The presenting author must declare that he/she will attend the meeting.
• The same presenting author cannot be assigned to more than 3 abstracts – co-authors should then be assigned as presenting authors.
• Submitted abstracts should not be published in any other journals and/or online publications or presented at any international congresses; however, former presentation at national meetings and/or non-cardiovascular specialists’ meetings does not disqualify.
• In case you have a paper accepted after your abstract was submitted, you may maintain the abstract for the AEPC meeting.
• Possibility to redraw abstract publication in case data are published after submission as abstract to AEPC.

ABSTRACT SUBMISSION GUIDELINES

• All abstracts must be written in English.
• All abstracts must be submitted online through the abstract submission system by the deadline given above. Abstracts that are sent via e-mail will not be included in the abstract review process.
• Please do NOT submit multiple copies of the same abstract.
• Use acronyms only when necessary and define all abbreviations and concepts in your abstract at first use.
• The submitting and presenting authors are required to ensure that all co-authors are aware of the content of the abstract before submission.
• Always make sure to check the final abstract with the system’s preview function before submission, and edit or replace as necessary. It is the authors’ responsibility to submit a correct abstract. Any errors in spelling, grammar or scientific fact will be reproduced as typed by the author.
• Only the accepted abstracts of presenting authors who have completed their registrations and paid their registration fees by the registration deadline for abstract presenters will be included in the Scientific Programme and the AEPC 2026 Supplement issue of the CitY (Cardiology in the Young) Journal.

Accepted abstracts will be published in the “Cardiology in the Young (CitY) Journal”. By submitting an abstract, the authors consent in giving AEPC permission to publish their abstracts in the abstract publication, supplement of the official Journal of the AEPC, the Cardiology in the Young (CiTY) Journal.

Since there will be no editing process on the abstracts, the authors are required to avoid any typing errors, misordering of the authors, wrong spelling/writing about the institutions, etc.

STEP 1 – Title, Submission Type, and Topic

• Title must be in UPPERCASE and limited to 30 words. An abstract must have a short, specific title (containing no abbreviations) that indicates the nature of the investigation.
• Use only generic drug names. Brand, product or company names must not be used in the abstract title or text. AEPC reserves the right to replace any brand name with a generic name.

• Presentation Preference: Please choose one of the following.
  – Oral presentation
  – Poster presentation
  – No preference
• The Scientific Committees reserves the right to change the presentation preference according to the requirements of the scientific program.

• Topic: A topic that is relevant for your abstract must be selected during Step 1 of the submission process. The Scientific Committees reserve the right to change the topics during the abstract review process.
  The topics for AEPC 2026 are listed on the congress website. Please CLICK HERE to review the topics before proceeding with the submission process.

STEP 2 – Authors and Institution Information

• First and last name of all the authors must be fully indicated correctly and in the right order. Please pay attention matching institutions to the right authors, and make sure that you select the “presenting author” correctly.
• The institution(s) of the authors should be indicated fully with the “department” and “institution” names while avoiding any abbreviations such as Dept., Univ., Inst., Hosp., etc. The department and institution details, city and country should be written with lower case while the initials of each word in capitals.
• In this step, you can add additional authors and define their roles in the abstract. The presenter could be the same person as the submitter - when setting up a new abstract, you are submitter by default. (Only admin can ascribe this status to one of your co-authors after adding them.) Simply tick the presenter box next to the name of the author, who shall receive author role
• To add an author, click 'Add author':
  • A new window will pop up. Enter name of your co-author in the field provided and click the 'Search' button. If the respective person will show up, author is already entered in database.

a.) Author in database: If the system finds a result, please select the author by clicking on the 'Add' icon.

b.) Author not in database: If the system does not find any results, you can add a new author to the database by clicking on 'Add new author' button.

• Fill in all bold/mandatory fields to add a new author to the system and hit 'Save'.
• The window closes, the person appears within your list of authors.

For more detailed information please visit Abstract Help page.

STEP 3 – Abstract Body

Abstract Body: Abstract body should not exceed 350 words. The title of the abstract, authors, institutions and keywords are not included in this limit, and those should not be entered in this section.

• Abstract body should consist of four sections given below:

Background and Aim: Clearly state the purpose of the abstract.
Methods: Describe your selection of observations or experimental subjects clearly.
Results: Present your results in a logical sequence in text, table and illustrations.
Conclusions: Emphasize new and important aspects of the study (perhaps as a discussion section) and the conclusions that are drawn from them.

• Standard abbreviations may be used without definition. Nonstandard abbreviations (kept to a minimum) must be placed in parentheses after the first use of the word or phrase abbreviated.
• Do not include the names or personal information of any patient participating in a study or trial.
• Phrases such as “results will be discussed” or “data will be presented” shall not be used.
• In order to be compatible with universal coding systems, only the special characters provided given on the system should be used. Please note that the abstracts in which other special characters are used may not be displayed correctly in the publications due to the coding systems.
• Use only generic drug names. Brand, product or company names must not be used in the abstract title or text. AEPC reserves the right to replace any brand name with a generic name.

STEP 4 – Keywords

Keywords should not be included in any of the sections of the abstract body and written only in the section dedicated for keywords.

• A minimum of 1 keyword is required and maximum 6 keywords can be entered.
• You may add up to 6 keywords by pressing 'Add' after each one.

STEP 5 – Affirmation

Agreement with affirmation items will be needed to be able to proceed with abstract submission

STEP 6 – Disclosure

Please declare if you or any of the co-authors have a significant financial interest, consultancy or other relationship with products, manufacturer(s) of products or providers of services related to the abstract.

STEP 7 – Preview and Finish

The submission summary will be shown ready for submission.

If there are any missing required fields, a message is displayed in red.

Please click the button Finish Submission to submit your abstract.

IMPORTANT NOTES:

• Please do NOT submit multiple copies of the same abstract.

Please make sure to save your username and password for future use.

You may edit your abstract up until the deadline date. Please make sure to final submit each time you edit your abstract in order to save your work. If you re-open your abstract, please make sure to check all author affiliations are correct before re-submitting.

You can make edits on your abstract only before submitting it to the Scientific Committee. After the submission is completed, no edits will be allowed on the system even if there is time until the deadline. In that case, if you have to make some edits on your abstract after submitting but before the submission deadline, please contact with the Meeting Organising Secretariat at (gholat@kenes.com).

REVIEW PROCESS AND ACCEPTANCE LETTERS

All submitted abstracts will be scored and passed through a review process after the submission closes.

The notification letters regarding the acceptance of abstracts will be sent at the end of January.

REGISTRATION OF ABSTRACT PRESENTERS

The presenting author(s) must be registered for the Annual Meeting latest by 2 February 2026, which is the registration deadline for abstract presenters.

The abstracts of unregistered presenting authors who do not complete registration (including payment) by this deadline will be removed from the final programme and all publications, including the CitY (Cardiology in the Young) Journal.

Thank you for submitting your work for consideration. Please contact us directly at gholat@kenes.com, should you have any specific inquiries.